Abstract
Background
Colorectal cancer (CRC) is a major cause to global cancer-related mortality. The development of colorectal cancer is linked to hereditary variables that exhibit variability.
Objectives
The objective of this investigation was to assess the potential correlation between microRNA gene polymorphisms and colorectal cancer (CRC) throughout the Iraqi population.
Methods
DNA samples were obtained from a cohort of 100 individuals diagnosed with the (CRC) disease, as well as 100 samples as control group. Four primers were designed to amplify four specific high-frequency variants found within microRNA molecules. These variants include Mir146a G\C, Mir423 A\C, Mir196a2, and Mir370. The genoty** of the PCR fragments was performed using the single-strand conformation polymorphism (SSCP) method, followed by direct sequencing of each genotype.
Results
Genoty** experiments confirmed the variability of four targeted variants, namely Mir146a G\C, Mir 423 A\C, Mir196a2, and Mir370 tend to exhibit a significant association with (CRC). Individuals with Mir146a: GC and Mir 423 A\C genotype showed a possible association with the increased risk of (CRC), respectively (P = 0.001; OD 0.50; CI 95% 0.33–0.76; P = 0.002; OD 0.53; CI 95% 0.36–0.80). Individuals with Mir196a2: TT and Mir370 GG genotype exhibited a potential association with (CRC) (P = 0.017; OD 0.44; CI 95% 0.22–0.86; P ≤ 0.001; OD 0.24; CI 95% 0.11–0.50).
Conclusions
The study reveals that single nucleotide polymorphisms (SNPs) in microRNA have a notable and distinct correlation with the heightened susceptibility to colorectal cancer (CRC).
Similar content being viewed by others
Background
Colorectal cancer (CRC) ranks as the third most prevalent form of cancer globally, with a reported incidence of over 1.84 million new cases in 2018. This places CRC behind only lung and breast cancers in terms of frequency [1, 2]. Colorectal cancer (CRC) has a higher prevalence in males compared to women, with an approximate difference of 30%. The incidence of CRC is generally low in adults below the age of 50, regardless of gender, but significantly rises with advancing age [3, 4]. Approximately 70% of people develop sporadic colorectal cancer (CRC) in the normal epithelial lining of the colon and rectum, without any hereditary predisposition [5]. Less than 10% of individuals diagnosed with colorectal cancer (CRC) exhibit a hereditary susceptibility, including conditions such as Familial Adenomatous Polyposis (FAP) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) [6, 7].
The completion of the human genomic project has recently drawn the attention of biomedical researchers to single nucleotide polymorphisms (SNPs) as a potential factor in the development of colorectal cancer (CRC) [8, 9]. Single nucleotide polymorphisms (SNPs) are inherent variations in DNA sequences that distinguish them from gene mutations. These variations are present in the general healthy population at a minimum frequency of 1% [6]. Single nucleotide polymorphisms (SNPs) are present in nearly all genes at varying rates and have the potential to impact the protein products of genes, potentially leading to an increased vulnerability to cancer. Among the genes that are currently recognized to possess single nucleotide polymorphisms (SNPs), a subset of particular interest is constituted by those that encode for microRNAs (miRNAs). MicroRNAs (miRNAs) are a group of small, single-stranded noncoding RNAs that have significant involvement in the control of gene expression by translational repression or degradation of target mRNA. These miRNAs have a profound impact on essential activities in a wide range of physiological processes [10,11,12]. Dysregulation of microRNAs (miRNAs) has been implicated in a diverse array of human disorders and can exert influence on the initiation and advancement of tumors through modulation of proto-oncogenes and tumor suppressor genes [13, 32]. In the process of PCR design, the focus was on four specific high-frequency single nucleotide polymorphisms (SNPs), namely Mir146a, Mir423, Mir370, and Mir196a2. These SNPs were targeted inside DNA fragments of varying lengths, specifically 257 bp, 215 bp, 306 bp, and 319 bp, respectively. The oligonucleotide sequences for PCR are presented in Table 1. The PCR experiments were carried out using a lyophilized PCR AccuPower PreMix (Promega Co., USA), with a final volume of 20 mL for each amplified fragment. Following the execution of polymerase chain reaction (PCR) tests, it was verified that the resulting PCR products exhibited sizes consistent with the anticipated values using electrophoresis conducted on agarose gels.
SSCP technique
The genoty** studies were performed with the PCR-single-strand conformation polymorphism (SSCP) technique. Subsequently, the PCR products were put into polyacrylamide gels with an 8% concentration, and the samples were allowed to migrate until they reached the bottom of the gels. The gels were subjected to staining with Ethidium bromide in accordance with the prescribed methodology [33]. The SSCP banding patterns were confirmed using Sanger dideoxy-sequencing, following the recommended protocols provided by Macrogen Inc., a company based in South Korea. The DNA chromatogram of each genotype was viewed utilizing Snap Gene Viewer version 4.0.4, a software produced by Insightful Science in Canada. The alignment of the reported variation with the matching DNA sequences was conducted using Bio Edit software, specifically version 7.1.
Statistical and functional analysis
The chi-square test was employed to assess the disparities in genotype distribution between the subjects and the control group. The odds ratio (OR) and 95% confidence interval (95% CI) were computed to assess the relative risk of colorectal cancer (CRC) and to examine the associations between the single nucleotide polymorphism (SNP) and clinicopathological features of individuals diagnosed with colorectal cancer. The predetermined level of significance was established at a value less than 0.05. The statistical analyses were conducted using SPSS version 28.
Results
Demographic characteristics of study subjects
The research encompassed a comprehensive sample size of 100 cases of colorectal cancer (CRC) and 100 control subjects. The clinical and pathological attributes of these individuals are detailed in Table 2. Significant statistical differences were seen between the patients and controls in relation to smoking status, gender, age, and alcohol intake. There were no statistically significant differences found between the two groups in terms of inclination and education level. The postoperative pathological stages were categorized as follows: stage I, with a total of 50 cases accounting for 50% of the sample; stage II, with 25 cases representing 25% of the sample; stage III, with 20 cases accounting for 20% of the sample; and stage IV, with 5 cases representing 5% of the sample.
Genoty** analysis
Four single nucleotide polymorphisms (SNPs) with the highest frequency were individually chosen. This study selected four single nucleotide polymorphisms (SNPs) as microRNAs (miRNAs): Mir146a, Mir423, Mir370, and Mir196a2. The analysis revealed four distinct banding patterns corresponding to the selected SNPs, indicating that the Mir146a, Mir423, Mir370, and Mir196a2 SNPs exhibit three genotypes each. The sequencing studies that were done successfully confirmed the presence of the three anticipated genotypes for all high-frequency single nucleotide polymorphisms (SNPs) that were examined. The electropherograms of the four examined single nucleotide polymorphisms (SNPs) exhibited the following genotypes: Mir146a (GG: GC: CC), Mir 423 (AA: AC: CC), Mir370 (GG: GA: AA), and Mir196a2 (CC: CT: TT) (Fig. 1).
The present work presents a schematic diagram illustrating the process of microRNA genoty** through the utilization of the PCR-SSCP-sequencing approach. In this study, we design four unique primers, denoted as A1, B1, C1, and D1. These primers were designed to amplify DNA fragments of certain lengths, 257 bp, 215 bp, 306 bp, and 319 bp. The purpose of these amplifications was to flank the regions associated with Mir146a, Mir423, Mir196a2, and Mir370, respectively. The genoty** technique employed in this study was PCR-SSCP as shown in figures A2, B2, C2, D2, specifically targeting SNPs. It was observed that all the targeted SNPs exhibited three distinct patterns of nucleic acid changes. The sequencing reactions of the targeted loci, as positioned in the amplified PCR fragments, are denoted as A3-A4, B3-B4, C3-C4, and D3-D4
In order to assess the Hardy–Weinberg equilibrium (HWE) of the research population, an analysis of the genetic diversity of the discovered polymorphic single nucleotide polymorphisms (SNPs) was conducted. Based on the chi-square values, the compatibility of the polymorphisms of all four discovered polymorphic single nucleotide polymorphisms (SNPs) with the Hardy–Weinberg equilibrium (HWE) was confirmed in both the control and colorectal cancer (CRC) groups at a significance level of 0.05 (see Table 3).
The distribution of Mir146a genotype in patients with colorectal cancer (CRC) was seen as follows: 45 individuals (45%) exhibited the homozygous GG genotype, 40 individuals (40%) exhibited the homozygous CC genotype, and 15 individuals (15%) exhibited the heterozygous GC genotype. The distribution of the Mir146a polymorphism genotypes in the control group was as follows: 65 participants (65%) had the homozygous GG genotype, 28 subjects (28%) had the homozygous CC genotype, and 7 subjects (7%) had the heterozygous GC genotype. The frequencies of G and C alleles in the subjected group were 52% and 57.5%, respectively, whereas in the control group, they were 68.5% and 31.5%, respectively. The distribution of genotypes for the miR146a gene in both patient and control groups is presented in Table 3.
In the patient group with colorectal cancer (CRC), the frequencies of the homozygous alleles AA and CC for the Mir423 polymorphism were observed to be 40% each. Additionally, the frequency of the heterozygous allele AC for this polymorphism was found to be 20% in the same patient group. In contrast, the healthy control group exhibited frequencies of 60%, 10%, and 30% for the polymorphic alleles AA, CC, and AC, respectively. The frequencies of the A and C alleles in the patient group were 50% and 50%, respectively, whereas in the control group, the rates were 65% and 35%, respectively.
In the study, the frequency of Mir370 polymorphism genotypes (AA, AG, and GG) was detected in both the patient and control groups. In the patient group, the observed frequencies were 40% for AA, 25% for AG, and 35% for GG genotypes. Conversely, in the control group, the observed frequencies were 70% for AA, 15% for AG, and 15% for GG genotypes. The frequencies of the A and G alleles in the sick group were 52.5% and 47.5%, respectively. In contrast, the control group had frequencies of 77.5% and 22.5% for the A and G alleles, respectively.
The frequencies of the Mir196a2 polymorphism alleles CC and TT in the patient group with colorectal cancer (CRC) were 50% and 32%, respectively, while the frequency of the heterozygous allele (CT) was 18%. In contrast, the healthy control group had frequencies of 70%, 15%, and 15% for the polymorphic alleles CC, TT, and CT, respectively, as indicated in Table 3 (Tables 4, 5).
Discussion
The high death rates observed in diverse populations for colorectal cancer (CRC) can be attributed to the significant number of cases being diagnosed at later stages. It is worth noting that CRC is the fourth most prevalent kind of cancer globally [34]. The issue at hand is a significant public health concern across several populations [35]. According to the World Health Organization (WHO), it has been projected that the incidence of new cases of colorectal cancer (CRC) and the associated mortality rates will see a significant rise of 77% and 80%, respectively, by the year 2030 [36, 37]. MicroRNA (miRNA) has been extensively studied and shown to have a strong correlation with the initiation and advancement of many cancer types. A number of microRNA (miRNA) biomarkers have been discovered as possible risk factors for colorectal cancer (CRC) [38, 39]. The increasing prevalence of colorectal cancer (CRC) among various populations prompts inquiries into the potential risk linked to certain alleles of MicroRNA (miRNA) in affected individuals. The objective of this study was to investigate the correlation between microRNA (miRNA) polymorphism and colorectal cancer (CRC) in the Iraqi population by employing genoty** techniques to analyze four frequently seen single nucleotide polymorphisms (SNPs) in microRNA (miRNA) sequences.
MicroRNAs (miRNAs) have a crucial role in regulating a wide range of biological and physiological processes. Consequently, their dysregulation, which can be caused by mutations, transcriptional changes, and epigenetic modifications, appears to be associated with this phenomena [44]. The selection of the PCR-SSCP method in the present genoty** strategy was based on its cost-effectiveness and high sensitivity in identifying genetic difference within the 200–350 bp range [45].
This study revealed a significant association between Mir146a and colorectal cancer (CRC) within the sample group. The potential correlation between these single nucleotide polymorphisms (SNPs) and the initiation and progression of colorectal cancer (CRC) can be clarified by further examination. The current investigation revealed that individuals with the GG genotype of the Mir146a gene exhibited an increased vulnerability to colorectal cancer (CRC). The observed result is not unexpected, as previous studies have demonstrated that the activity of Mir146a, Additionally, it has been found that individuals with the GG genotype have higher expression levels of Mir146a, leading to an increase in its activity [46, 47]. Several investigations have been undertaken on colon, lung, breast, and hepatic cancer, which support our discovery of an elevated cancer risk associated with the Mir146a CG genotype [48,49,50]. The study on colon cancer did not acknowledge this particular correlation [51]. A subsequent investigation was conducted on a community in Italy, wherein it is widely acknowledged that cancer arises as a result of the interplay between genetic factors and environmental influences. On the contrary, a meta-analysis conducted on single nucleotide polymorphism (SNP) studies of colorectal cancer (CRC) microRNAs (miRNAs) revealed that individuals of Asian descent exhibit a tendency toward a correlation between the mir-146a SNP and an elevated risk of CRC [52].
Several studies have demonstrated that Mir146a, along with its prevalent polymorphism, rs2910164, which involves a G to C substitution, is found inside the sequence of the Mir146a precursor. In the present work, we want to investigate this miRNA hotspot in colorectal cancer (CRC) for the first time. The single nucleotide polymorphism (SNP) in question converts a G:U base pair to a C:U mismatch. As a consequence, there is a decrease in the levels of both pre- and mature Mir146a [57, 58]. Another study asserts that the Mir423 single nucleotide polymorphism (SNP) plays a protective effect in relation to the risk of breast cancer [22]. Our study conducted an observation of an elevated susceptibility to colorectal cancer (CRC) in individuals with the Mir423 single nucleotide polymorphism (SNP) CC genotype. A study conducted by [58] demonstrated an elevated susceptibility to colorectal cancer (CRC) when Mir 423 is accompanied by other mutations. These findings demonstrate a multifaceted interplay between single nucleotide polymorphisms (SNPs), other genetic variations, and the combined effects of environmental and ethnic factors.
The current study aimed to examine the genetic polymorphism of Mir 370 in colorectal cancer (CRC). Specifically, we explored the mir-370 single nucleotide polymorphism (SNP) rs2279398G > A in case–control studies to assess its association with CRC risk. Our findings revealed that this association exhibited diverse directions [59, 60]. Numerous studies have demonstrated that the rs2279398 polymorphism, which is situated in the 3’-UTR region of the DOK3 gene, has the ability to impact the efficacy of miRNA binding. Consequently, this polymorphism may have a role in the modulation of tumor suppression, while previous studies have suggested that the findings presented here could offer valuable SNP information for elucidating the specific biological implications of cancer progression and treatment resistance in individuals with colorectal cancer (CRC). In a similar vein, Zhang and colleagues have documented that the presence of the KRAS 3'-UTR polymorphism has the potential to serve as a predictive factor for the response of patients with wild-type KRAS colorectal cancer who are undergoing cetuximab monotherapy [61, 62]. However, despite the growing body of evidence indicating the significance of DOK3 in several facets of carcinogenesis, there remains a lack of clarity on the potential impact of the DOK3 (rs2279398) polymorphism on protein expression.
While rs11614913 SNP may not be as widely recognized as rs2279398 SNP, it has also been associated with the progression of colorectal cancer. Additionally, it has been found to be associated with elevated susceptibility to various other types of cancer [44, 72].
The main limitation of this study is the small sample size, which may affect the reported results by not fully reflecting the actual effects on the development and advancement of colorectal cancer (CRC). The utilization of a small sample size in this study may potentially affect the statistical significance of the findings. Therefore, it is advisable to reproduce the aforementioned technique using a larger sample size in order to acquire more reliable conclusions generated from a thorough investigation.
In summary, the genoty** investigations conducted on four variants within microRNAs demonstrated a significant association between the polymorphisms of Mir146a, Mir196a2, Mir370, and Mir423 single nucleotide polymorphisms (SNPs) and colorectal cancer (CRC) in the Iraqi people. Individuals harboring the Mir423: AC and Mir370: AG genotypes exhibited a heightened vulnerability to colorectal cancer (CRC). Both single nucleotide polymorphisms (SNPs) possess the potential to serve as biomarkers for the evaluation of colorectal cancer (CRC) in the Iraqi population being studied. However, it is imperative to do additional research in order to substantiate the molecular diagnostic capabilities that have been alluded to on a more extensive level.
Conclusions
The study of our aggregated data reveals that single nucleotide polymorphisms (SNPs) in microRNA have a notable and distinct correlation with the heightened susceptibility to colorectal cancer (CRC). Nevertheless, this study proposes the utilization of a more comprehensive range of examined samples in order to obtain additional insights into the association between both single nucleotide polymorphisms (SNPs) and the susceptibility to colorectal cancer (CRC).
Availability of data and materials
The data presented in this study are classified as confidential, in accordance with the regulations set forward by the Institutional Review Board of the University of Babylon. The analysis of the medical record was conducted with the authorization of the medical board at Merjan Cancer Center. The genoty** data can be obtained upon request from the Laboratory of Biotechnology, under the supervision of Dr. Zahraa Isam., zahraa.isam@science.uoqasim.edu.iq).
Abbreviations
- SNPs:
-
Single nucleotide polymorphisms
- CRC:
-
Colorectal cancer
- mir:
-
MicroRNA
- 3'-UTR:
-
3 Untranslated region
- SSCP:
-
Single-strand conformation polymorphisms
- PCR:
-
Polymerase chain reaction
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Van der Jeught K, Xu HC, Li YJ, Lu XB, Ji G (2018) Drug resistance and new therapies in colorectal cancer. World J Gastroenterol 24:3834–3848. https://doi.org/10.3748/wjg.v24.i34.3834
Falzone L, Scola L, Zanghì A, Biondi A, Di Cataldo A, Libra M, Candido S (2018) Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development. Aging 10:1000–1014. https://doi.org/10.18632/aging.101444
Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383:1490–1502. https://doi.org/10.1016/S0140-6736(13)61649-9
Strul H, Arber N (2007) Screening techniques for prevention and early detection of colorectal cancer in the average-risk population. Gastrointest Cancer Res 1:98–106
Schetter AJ, Okayama H, Harris CC (2012) The role of microRNAs in colorectal cancer. Cancer J 18(3):244–252
Fadhil W, Ibrahem S, Seth R, AbuAli G, Ragunath K, Kaye P et al (2012) The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer. Histopathology 61(6):1117–1124
Hood L, Galas D (2003) The digital code of DNA. Nature 421(6921):444–448
Amani D, Khalilnezhad A, Ghaderi A, Niikawa N, Yoshiura K (2014) Transforming growth factor beta1 (TGFbeta1) polymorphisms and breast cancer risk. Tumour Biol 35(5):4757–4764
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Garo LP, Murugaiyan G (2016) Contribution of MicroRNAs to autoimmune diseases. Cell Mol Life Sci 73:2041–2051
Li X, Nie J, Mei Q, Han WD (2016) MicroRNAs: novel immunotherapeutic targets in colorectal carcinoma. World J Gastroenterol 22:5317–5331
Chae YS et al (2013) A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer. Anticancer Res 33:3233–3239
Nakajima G, Hayashi K, ** Y, Kudo K, Uchida K, Takasaki K, Yamamoto M, Ju J (2006) Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in Colon Cancer. Cancer Genom Proteom 3:317–324
Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:425–436
Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R (2007) Altered expression of miR- 21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72:397–402
Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R (2012) Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med 16:8–21
Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H (2009) Common geneticvariants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30:79–84
Chen H, Sun LY, Chen LL, Zheng HQ, Zhang QF (2011) A variant in microRNA-196a2 is not associatedwith susceptibility to and progression of colorectal cancer in Chinese. Intern Med J. https://doi.org/10.1111/j.1445-5994.2011.02434.x
Omrane I, Kourda N, Stambouli N, Privat M, Medimegh I, Arfaoui A et al (2014) MicroRNAs 146a and 147b biomarkers for colorectal tumor’s localization. Biomed Res Int 2014:584852
Hezova R, Kovarikova A, Bienertova-Vasku J, Sachlova M, Redova M, Vasku A et al (2012) Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol 18(22):2827–2831
Smith RA, Jedlinski DJ, Gabrovska PN, Weinstein SR, Haupt L, Griffiths LR (2012) A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genom Proteom 9(3):115–118
Ma Y, Wang R, Zhang J, Li W, Gao C, Liu J et al (2014) Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population. Genet Test Mol Biomark 18(7):516–524
Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q (2011) MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med 15(1):14–23
Yungang W, **aoyu L, Pang T, Wenming L, Pan X (2014) miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother 68:149–154
Chen XP, Chen YG, Lan JY, Shen ZJ (2014) MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG. Cancer Lett 353:201–210
Wu Z, Sun H, Zeng W, He J, Mao X (2012) Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS ONE 7:e45825
Luo P, He T, Jiang R, Li G (2015) MicroRNA-423-5p targets O-GlcNAc transferase to induce apoptosis in cardiomyocytes. Mol Med Rep 12:1163–1168
Li FX, Yang XX, Hu NY, Du HY, Ma Q, Li M (2012) Single-nucleotide polymorphism associations for colorectal cancer in southern chinese population. Chin J Cancer Res 24(1):29–35
Qi JH, Wang J, Chen J, Shen F, Huang JT, Sen S et al (2014) High-resolution melting analysis reveals genetic polymorphisms in MicroRNAs confer hepatocellular carcinoma risk in Chinese patients. BMC Cancer 14:643
Abdul-Hadi Chabuk H, Jameel ZI (2021) Relationship between the monoamine oxidase gene overactivity and the otherpathophysiological and behavioral parameters implicated in memory deficiency in albino Winstar rats as Alzheimer’s diseasemodel. J Appl Nat Sci 13(4):1274–1282. https://doi.org/10.31018/jans.v13i4.3024
Jameel ZI, Lawi ZK, Al-Dujaili NH (2019) Investigation of micro RNA gene polymorphism (Rs11614913) inpatients with type 2 diabetes in Najaf City. Biochem Cell Arch 19(1):2027–2030
Byun SO, Fang Q, Zhou H, Hickford JGH (2009) An effectivemethod for silver-staining DNA in large numbers of poly-acrylamide gels. Anal Biochem 385(1):174–175
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749–1768
Moridikia A, Mirzaei H, Sahebkar A, Salimian J (2018) MicroRNAs: potential candidates for diagnosis and treatment of colorectal cancer. J Cell Physiol 233(2):901–913
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683–6891
Rinaldi A, Poretti G, Kwee I, Zucca E, Catapano CV, Tibiletti MG et al (2007) Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma. Leuk Lymphoma 48(2):410–412
Li BS, Wang XY, Ma FL, Jiang B, Song XX, Xu AG (2011) Is high resolution melting analysis (HRMA) accurate for detection of human disease-associated mutations? A meta analysis. PLoS ONE 6(12):e28078
Liu J, **e B, Chen S, Jiang F, Meng W (2014) Association study of two inflammation-related polymorphisms with susceptibility to hepatocellular carcinoma: a meta- analysis. BMC Med Genet 15:92
Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, Simi L et al (2011) Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med 49(12):2073–2080
Qu Y, Shi B, Hou P (2017) Activated ERK: an emerging player in miRNA Downregulation. Trends Cancer 3:163–165. https://doi.org/10.1016/j.trecan.2017.01.002
Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004. https://doi.org/10.1038/sigtrans.2015.4
Badi MA, Al-Shuhaib MBS, Aljubouri TRS et al (2021) Rapid and optimized protocol for efficient PCR-SSCP genoty** for wide ranges of species. Biologia (Bratisl) 76:2413–2420
Wrzosek M, Sawicka A, Wrzosek M et al (2019) Age at onset of obesity, transcription factor 7-like 2 (TCF7L2) rs7903146 polymorphism, adiponectin levels and the risk of type 2 diabetes in obese patients. Arch Med Sci AMS. 15:321
Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY et al (2008) A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29(11):2126–2131
Li M (2012) Single-nucleotide polymorphism associations for colorectal cancer in southern chinese population. Chin J Cancer Res 24(1):29–35
Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J et al (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30(1):79–84
Chae YS, Kim JG, Lee SJ, Kang BW, Lee YJ, Park JY et al (2013) A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer. Anticancer Res 33(8):3233–3239
Hu X, Li L, Shang M, Zhou J, Song X, Lu X et al (2014) Association between microRNA genetic variants and susceptibility to colorectal cancer in Chinese population. Tumour Biol 35(3):2151–2156
Du W, Ma XL, Zhao C, Liu T, Du YL, Kong WQ et al (2014) Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility. Asian Pac J Cancer Prev 15(2):1047–1055
Ji HH, Huang GL, Yin HX, Xu P, Luo SY, Song JK (2015) Association between microRNA-196a2 rs11614913, microRNA-146a rs2910164, and microRNA-423rs6505162 polymorphisms and esophageal cancer risk: a meta-analysis. Meta Gen. 3:14–25
Guo H, Wang K, **ong G, Hu H, Wang D, Xu X, Guan X, Yang K, Bai Y (2010) A functional varient inmicroRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han. Fam Cancer 9:599–603. https://doi.org/10.1007/s10689-010-9370-5
Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A (2008) Common SNPin pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105:7269–7274
Lin J, Huang S, Wu S, Ding J, Zhao Y, Liang L et al (2011) MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis 32(11):1641–1647
Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X (2008) Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Can Res 68(7):2530–2537
Kontorovich T, Levy A, Korostishevsky M, Nir U, Friedman E (2010) Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer 127:589–659
Min KT, Kim JW, Jeon YJ, Jang MJ, Chong SY, Oh D et al (2012) Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog 51(Suppl 1):E65-73
Tarraga Lopez PJ, Albero JS, Rodriguez-Montes JA (2014) Primary and secondary prevention of colorectal cancer. Clin Med Insights Gastroenterol 7:33–46
Zoratto F, Rossi L, Verrico M, Papa A, Basso E, Zullo A, Tomao L, Romiti A, Lo Russo G, Tomao S (2014) Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis. Tumour Biol 35:6195–6206
Zhang W, Winder T, Ning Y, Pohl A, Yang D, Kahn M, Lurje G, Labonte MJ, Wilson PM, Gordon MA, Hu-Lieskovan S, Mauro DJ, Langer C, Rowinsky EK, Lenz HJ (2011) A let-7 microRNAbinding site polymorphism in 3’-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann Oncol 22:104–109
Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y (2009) microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 69:5970–5977
Zhan JF, Chen LH, Chen ZX, Yuan YW, **e GZ, Sun AM, Liu Y (2011) A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch MedRes 42:144–148. https://doi.org/10.1016/j.arcmed.2011.04.001
Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, Sutter C, Wappenschmidt B, Dick M, Arnold N (2010) Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrancealleles in German and Italian familial breast cancer cases. Hum Mutat 31:E1052–E1057. https://doi.org/10.1002/humu.21141
Cortez MA, Ivan C, Zhou P, Wu X, Ivan M, Calin GA (2010) microRNAs in cancer: from bench to bedside. Adv Cancer Res 108:113–157. https://doi.org/10.1016/b978-0-12-380888-2.00004-2
Liu Y, He A, Liu B, Zhong Y, Liao X, Yang J et al (2018) rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated metaanalysis. Onco Targets Ther 11:1121–1139
Jiang J, Jia ZF, Cao DH, Wu YH, Sun ZW, Cao XY (2016) Association of the miR-146a rs2910164 polymorphism with gastric cancer susceptibility and prognosis. Future Oncol 12(19):2215–2226
Zhu L, Chu H, Gu D, Ma L, Shi D, Zhong D et al (2012) A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population. DNA Cell Biol 31(3):350–354
Chen H, Sun LY, Chen LL, Zheng HQ, Zhang QF (2012) A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Intern Med J 42(6):e115–e119
Wan D, Gu W, Xu G, Shen C, Ding D, Shen S et al (2014) Effects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis. Clin Transl Oncol 16(9):792–800
Zhan JF, Chen LH, Chen ZX, Yuan YW, **e GZ, Sun AM et al (2011) A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res 42(2):144–148
Mirtalbi H, Heydari-Nasrabadi M, Pourhosseigholi M, Asadzadeh-Aghdai H (2014) Association of miR-196a2 (rs11614913) polymorphism with colorectal cancer in Tehran population. Med Sci 23(4 and 1):11–15
Acknowledgements
The author would like to express their gratitude to all the collaborative partnerships and voluntary participants who contributed to the successful execution of this study. The Middle-Euphrates Cancer Center (MECC) located in Najaf province and the Merjan Cancer Center (MCC) situated in Babil province are acknowledged for their contribution in giving the samples. Additionally, the postgraduate laboratory unit at the College of Science, University of Babylon, is recognized for offering certain resources to support the preliminary preparations of the samples.
Funding
The author declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
The process of collecting samples and conducting genoty** was supervised by zahraa Isam Jameel.
Corresponding author
Ethics declarations
Ethical approval and consent to participate
Institutional Ethics Committee Involving Humans of the University of Babylon (Babel, Iraq) ratified this study (IECIH/UOK 088/2020; CAAE 08802212). All subjects signed a written informed consent form before participation, and the study was conducted in accordance with Helsinki’s Declaration.
Competing interests
No conflict of interest is reported by the author.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jameel, Z.I. Four microRNA gene polymorphisms are associated with Iraqi patients with colorectal cancer. Egypt J Med Hum Genet 25, 47 (2024). https://doi.org/10.1186/s43042-024-00521-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s43042-024-00521-6